
Prescription Drug Name:
Triamcinolone Acetonide Ointment USP, 0.5%, For Dermatologic Use Only, Not For Ophthalmic Use
ID:
6985b062-b223-4b97-e053-2991aa0ae06a
Code:
34391-3
DESCRIPTION
id: 6988b4be-1963-8286-e053-2991aa0a5f0f
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
24H
31FO
6, M.W. 434.51; CAS Reg. No. 76-25-5.
CLINICAL PHARMACOLOGY
id: 6985b062-b225-4b97-e053-2991aa0ae06a
displayName: CLINICAL PHARMACOLOGY SECTION
FDA Article Code: 34090-1
INDICATIONS AND USAGE
id: 6985b062-b227-4b97-e053-2991aa0ae06a
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9
CONTRAINDICATIONS
id: 6985b062-b228-4b97-e053-2991aa0ae06a
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3
ADVERSE REACTIONS
id: 6985b062-b233-4b97-e053-2991aa0ae06a
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4
OVERDOSAGE
id: 6985b062-b234-4b97-e053-2991aa0ae06a
displayName: OVERDOSAGE SECTION
FDA Article Code: 34088-5
DOSAGE AND ADMINISTRATION
id: 6985b062-b235-4b97-e053-2991aa0ae06a
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7
OCCLUSIVE DRESSING TECHNIQUE
Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions. Apply a thin film of ointment to the lesion, cover with a pliable nonporous film, and seal the edges. If needed, additional moisture may be provided by covering the lesion with a dampened clean cotton cloth before the nonporous film is applied or by briefly wetting the affected area with water immediately prior to applying the medication. The frequency of changing dressings is best determined on an individual basis. It may be convenient to apply triamcinolone acetonide ointment under an occlusive dressing in the evening and to remove the dressing in the morning (i.e., 12-hour occlusion). When utilizing the 12-hour occlusion regimen, additional ointment should be applied, without occlusion, during the day. Reapplication is essential at each dressing change.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
HOW SUPPLIED
id: 6985b062-b236-4b97-e053-2991aa0ae06a
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
STORAGE
id: 6985b062-b237-4b97-e053-2991aa0ae06a
displayName: STORAGE AND HANDLING SECTION
FDA Article Code: 44425-7
Teligent Pharma, Inc.
Buena, NJ 08310
Revised: 12/16